GAGail M. Annich

Gail M. Annich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gail M. Annich has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    More to Learn About Acquired Von Willebrand Syndrome

    by Ali B.V. McMichael, Eddy Fan, Gail M. Annich

  • Extracorporeal Life Support Organization (ELSO): 2020 Pediatric Respiratory ELSO Guideline

    by Christina Maratta, Renee M. Potera, Grace van Leeuwen, Andrés Castillo Moya, Lakshmi Raman, Gail M. Annich, Thomas V. Brogan, Mark Davidson, Graeme MBBS MacLaren, Giles Md Peek

    Disclaimer: This guideline describes prolonged extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO), applicable to Pediatric respiratory failure. These guidelines describe useful and safe practice, prepared by ELSO and based on extensive experience and are considered consensus guidelines. These guidelines are not intended to define standard of care and are revised at regular intervals as new information, devices, medications, and techniques become available.


  • Open Access

    Extracorporeal life support for acute respiratory distress syndrome due to severe Legionella pneumonia

    by B Bryner, J Miskulin, C Smith, E Cooley, R Grams, R Bartlett, G Annich, Gb Mychaliska

    Legionella is a common cause of community-acquired pneumonia (CAP) and is second only to Pneumococcal pneumonia as a cause of severe CAP that requires treatment in an intensive care unit. We report a case series of patients with severe Legionella pneumonia who developed the acute respiratory distress syndrome (ARDS), failed to improve with mechanical ventilation alone and required extracorporeal life support (ECLS). We performed a retrospective study of all patients treated with ECLS at our institution for severe ARDS as a result of Legionella pneumonia from 1994 to 2006. A total of twelve patients with a diagnosis of Legionella pneumonia were treated with veno-venous (VV) ECLS over this time period. Nine of these twelve (75%) were successfully treated and weaned off ECLS and 8 patients (67%) survived to hospital discharge. Two (13%) died of multisystem organ failure, one patient (8%) died from global hypoxic encephalopathy and one (8%) was weaned from ECLS, but ultimately died of liver failure. Renal failure requiring some form of continuous dialysis occurred in seven patients (58%) and the survival for this sub-set of patients was 43%. Extracorporeal life support for severe ARDS associated with Legionella pneumonia is an effective treatment option when mechanical ventilation fails, especially when introduced early in the course.